Afuco™ Anti-PDCD1 ADCC Therapeutic Antibody (Pidilizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human PD-1. Pidilizumab is a monoclonal antibody designed for the treatment of cancer and infectious diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-900 |
| Pricing | Inquiry |
| Host | Human |
| Target | PDCD1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | IP, IF, FuncS, FC, Neut, ELISA |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |